iSTAR Medical SA

Companies
iSTAR Medical SA
Applications
Micro-Invasive Glaucoma Surgery Device ...

Micro-Invasive Glaucoma Surgery Device (MIGS) for Clinical Trial Program Supports - Medical / Health Care - Clinical Services

FromiSTAR Medical SA

SHARE

A comprehensive clinical trial program supports the development of MINIject^®, with positive combined results at two years from the STAR-I and STAR-II clinical trials shown below. ¹

Most popular related searches

intraocular pressure

clinical program

eye irritations

cataract surgery

skin sensitization

glaucoma surgery

Intraocular Pressure (IOP)

Meaningful IOP reduction to
~40% mean IOP reduction after two years
Trials designed with stand-alone procedure

Medication

Nearly half of patients medication-free after two years
Medication use reduced by 45% two years post-procedure
Significant reduction or elimination of medication side-effects such as eye irritation/burning, eye pain, and skin sensitivity/irritation around the eye ²

Reduced complications

Low re-intervention rate up to two years
Bleb-free and conjunctiva sparing procedure - no needling, no MMC required
Very low number of patients with >30% central endothelial cell density (ECD) loss at two years

Evidence-based data on safety and efficacy

More than 150 patients in clinical trials
11 trial centers throughout Europe, India and Latin America
MINIject assessed as stand-alone procedure- no enhancement of outcomes from joint cataract surgery
Published results after two-years of follow-up